CDKN2A and myeloid neoplasm: The genetic profile of these MYC- translocated T-ALL is characterized by concomitant abnormalities, including CDKN2A/B deletions, PTEN inactivation, and mutations typical of myeloid neoplasms, such as DNMT3A (54).